Persistence at 12 months with B/F/TAF was numerically greater compared with CAB + RPV for both groups but did not reach statistical significance.
← all excerpts
Antiretroviral therapy persistence among treatment-experienced people with HIV and mental health disorders and/or substance use disorders in the USA (2017-2024): a retrospective cohort study.
1
—
—